|Year : 2013 | Volume
| Issue : 2 | Page : 98-100
Imaging in classic form of maple syrup urine disease: A rare metabolic central nervous system
Aditi Jain, K Jagdeesh, Ranoji Mane, Saurabh Singla
Department of Radiodiagnosis, M S Ramaiah Medical College and Teaching Hospital, Bangalore, Karnataka, India
|Date of Web Publication||13-Aug-2013|
B 101, M.S Palazzo, 491, Jakkur Main Road, Yelahanka Hobli, Bangalore - 560 064, Karnataka
Source of Support: None, Conflict of Interest: None
Maple syrup urine disease (MSUD) is a rare autosomal recessive disorder of branched-chain amino acid metabolism. The condition gets its name from the distinctive sweet odour of affected infants' urine. MSUD is caused by a deficiency of the branched-chain α-ketoacid dehydrogenase enzyme complex, leading to accumulation of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. Imaging is characterestized by MSUD oedema affecting the myelinated white matter. We present a neonate with classic type of MSUD and its imaging features on computed tomography, conventional magnetic resonance imaging, diffusion-weighted imaging, and magnetic resonance spectroscopy.
Keywords: Brain, branched-chain amino acids, diffusion-weighted magnetic resonance imaging, maple syrup urine disease
|How to cite this article:|
Jain A, Jagdeesh K, Mane R, Singla S. Imaging in classic form of maple syrup urine disease: A rare metabolic central nervous system. J Clin Neonatol 2013;2:98-100
|How to cite this URL:|
Jain A, Jagdeesh K, Mane R, Singla S. Imaging in classic form of maple syrup urine disease: A rare metabolic central nervous system. J Clin Neonatol [serial online] 2013 [cited 2019 Jul 16];2:98-100. Available from: http://www.jcnonweb.com/text.asp?2013/2/2/98/116411
| Case report|| |
Maple syrup urine disease (MSUD) is a rare inherited autosomal recessive disorder of branched-chain amino acid (BCAA) metabolism presenting with life-threatening cerebral edema and dysmyelination in affected individuals. MSUD affects approximately 1 out of 180,000 infants  and has a much higher prevalence in children of Amish, Mennonite, and Jewish descent. , We present a case report of a baby boy born to consanguineous married parents, who presented on the 8 th postnatal day with history of poor feeding, lethargy, and tonic-clonic seizures, since 2 days. The child was born at term (39 weeks) after an uneventful pregnancy and normal vaginal delivery.
The baby was apparently normal in the first week of postnatal life. On 8 th day, clinical systemic examination showed hypotonia and poor neonatal reflexes. Routine biochemical evaluation including serum electrolytes: Sodium 138 (133-145 mEq/L), potassium 4.2 (3.5-5.3 mEq/L), chloride 102 (98-106 mEq/L), calcium 8.6 (7.6-10.4 mg/dL), and magnesium levels 1.6 (1.40-2.55 mg/dL) were within normal limits.
Non-enhanced computed tomography (NECT) scan of the brain showed bilateral symmetrical white matter hypodensities in the posterior limb of internal capsule, thalami, midbrain, and cerebellar white matter [Figure 1].
|Figure 1: Seven‑day‑old newborn. NECT of the brain, axial images shows bilaterally symmetrical hypodensities in the posterior limb of internal capsule (blue arrow in Figure 1a) and in the midbrain (blue arrow in Figure 1b) with compressed ventricles and gyral swelling|
Click here to view
Conventional magnetic resonance imaging (MRI) showed bilateral symmetric white matter hyperintensites in the posterior limb of internal capsule, thalami, midbrain, corticospinal tracts, and cerebellar white matter on T2-weighted magnetic resonance (MR) sequence [Figure 2]a and b. Turbo inversion recovery magnitude sequence showed similar findings as T2-weighted images. No abnormalities were detected on T1-weighted images.
|Figure 2: Seven‑day‑old newborn. DWIs with corresponding ADC maps demonstrate restricted diffusion in the posterior limbs of the internal capsules (blue arrows in Figure 2a and 2b), pons, corticospinal tracts (blue arrow in Figure 2c), and cerebellar white matter (Figures 2c and 2d)|
Click here to view
Diffusion-weighted imaging (DWI) showed characteristic pattern of bilateral symmetrical restricted diffusion within the myelinated areas in the posterior limb of the internal capsule, centrum semiovale, corona radiata, corticospinal tract, thalami, posterior aspect of the mid brain, pons, middle cerebellar peduncle, medulla, and cerebellar white matter , attributed to intramyelinic edema  [Figure 3]a and b.
|Figure 3: Seven‑day‑old newborn. Axial T2‑weighted MR images shows bilateral symmetrical hyperintensities in posterior limb of internal capsule (blue arrow in Figure 3a), central cerebellar white matter, and in the corticospinal tracts (blue arrow in Figure 3b)|
Click here to view
Multivoxel proton MR spectroscopy showed the presence of BCAAs and branched-chain α-keto acids resonating at 0.9-1.0 ppm, which are seen especially during a metabolic crisis , [Figure 4] and [Figure 5].
Three days later tandem mass spectroscopy revealed increased levels of BCAAs (valine, leucine, and isoleucine), confirming the diagnosis of MSUD.
| Discussion|| |
It is a rare autosomal recessive disorder, associated with defects in the branched- chain ketoacid dehydrogenase complex. It is divided into four major categories: (1) Classic, (2) intermediate, (3) intermittent, and (4) thiamine responsive, which carry differing symptoms and prognostic factors.  The exact cause for brain injury is not clearly understood. According to a study by Zinnanti et al.,  they suggest two converging mechanisms of brain injury in MSUD including: (i) Neurotransmitter deﬁciencies and growth restriction associated with BCAA accumulation and (ii) energy deprivation through Krebs cycle disruption associated with branched-chain ketoacid accumulation. This disease leads to accumulation of BCAA and metabolites (neurotoxic). The rapid accumulation of leucine in particular causes neurological symptoms. Increased plasma isoleucine is associated with maple syrup odour.
Neonates will be normal at birth, presents after disease-free interval, usually within the 4-7 days of life with poor feeding, vomiting, poor weight gain, and increasing lethargy. In crisis, patient's urine smells like maple syrup, secondary to the large accumulation of isoleucine. Maple syrup odour may be difficult to identify in first few days of life.
Imaging features are diagnostic in the early weeks of life. Classic appearing MSUD edema involving: Cerebellar white matter, brain stem, globus pallidus, thalamus, cerebral peduncles, and corticospinal tracts.
NECT of brain shows diffuse bilaterally symmetrical edema not sparing brainstem and cerebellum. 
DWI shows marked restriction and decreased apparent diffusion coefficient (ADC) which indicates MSUD edema is an intracellular oedema (cytotoxic oedema). DWI is more sensitive than conventional MRI in detecting MSUD brain alterations and it can become a useful tool for early diagnosis and follow-up of metabolic diseases in neonates.  Kilicarlsan et al.,  reported six cases with DWI in which the changes in all patients were reversed with treatment without evidence of volume loss or persistent tissue damage.
Acute "metabolic rescue" to reverse cerebral edema may require hemodialysis during acute crisis to limit neurotoxicity/damage. Metabolically appropriate diet (protein-modified) minimizes severity and prevent deficiencies of essential amino acids. Dietary therapy must be lifelong. If treated with low-BCAA diet and peritoneal dialysis within a few days from the onset of the symptoms, most patients survive and develop only minimal or no neurological deﬁcits.
The changes in cell osmolarity and metabolism can reverse completely after metabolic correction in metabolic decompensated MSUD with clinical neurological improvement. ,
| Conclusion|| |
MSUD is a rare autosomal recessive disorder of BCAA metabolism. Early imaging diagnosis of this condition can prevent the progress of neurological deﬁcits and help in appropriate management of the disease.
| References|| |
|1.||Mary K. Maple syrup urine disease. Rare diseases-June 2004. Available from: http://rarediseases.about.com/od/rarediseases1/a/062004.htm [Last accessed on 2004]. |
|2.||Puffenberger EG. Genetic heritage of Old Order Mennonites of Southeastern Pennsylvania. Am J Med Genet C Semin Med Genet 2003;121:18-31. |
|3.||Kilicarslan R, Alkan A, Demirkol D, Toprak H, Sharifov R. Maple syrup urine disease: Diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 2012;30:522-5. |
|4.||Thomas B, Al Dossary N, Widjaja E. MRI of childhood epilepsy due to inborn errors of metabolism. AJR Am J Roentgenol 2010;194:W367-74. |
|5.||Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003;45:393-9. |
|6.||Taccone A, Schiaffino MC, Cerone R, Fondelli MP, Romano C. Computed tomography in maple syrup urine disease. Eur J Radiol 1992;14:207-12. |
|7.||Chuang D, Shih V. Disorders of branched-chain amino acid and keto acid metabolism. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Basis of Inherited Disease. 7 th ed. New York: McGraw-Hill; 1995. p. 1239-77. |
|8.||Zinnanti WJ, Lazovic J, Grifﬁn K, Skvorak KJ, Paul HS, Homanics GE, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 2009;132:903-18. |
|9.||Cavalleri F, Berardi A, Burlina AB, Ferrari F, Mavilla L. Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology 2002;44:499-502. |
|10.||Naughten ER, Jenkins J, Francis DE, Leonard JV. Outcome of maple syrup urine disease. Arch Dis Child 1982;57:918-21. |
|11.||Kaplan P, Mazur A, Field M, Berlin JA, Berry GT, Heidenreich R, et al. Intellectual outcome in children with maple syrup urine disease. J Pediatr 1991;119:46-50. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
|This article has been cited by|
||A case of classical maple syrup urine disease that was successfully managed by living donor liver transplantation
| ||Chika Takano,Mika Ishige,Erika Ogawa,Hiromi Usui,Reiko Kagawa,Go Tajima,Ryoji Fujiki,Toshiyuki Fukao,Koichi Mizuta,Tatsuo Fuchigami,Shori Takahashi |
| ||Pediatric Transplantation. 2017; : e12948 |
|[Pubmed] | [DOI]|
||Neuroimaging of Pediatric Metabolic Disorders with Emphasis on Diffusion-Weighted Imaging and MR Spectroscopy: A Pictorial Essay
| ||Kofi-Buaku Atsina,Lauren W. Averill,Vinay V. R. Kandula |
| ||Current Radiology Reports. 2017; 5(11) |
|[Pubmed] | [DOI]|
||Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease
| ||Wei Xia,Wenzhong Yang |
| ||Journal of Pediatric Endocrinology and Metabolism. 2015; 28(7-8) |
|[Pubmed] | [DOI]|